Public Perceptions of Very Low Nicotine Content on Twitter: Observational Study.

What Was Tested

Researchers studied Therapeutic nicotine (patch, non-peptide) in this observational study publication.

This study aimed to understand public perception and discussion of very low nicotine content (VLNC) on Twitter (rebranded as X in July 2023).

The researchers used an inductive method to assess the public perception and discussion of VLNC on Twitter.

Why It Was Studied

Nicotine is a highly addictive agent in tobacco products.

On June 21, 2022, the US Food and Drug Administration (FDA) announced a plan to propose a rule to establish a maximum nicotine level in cigarettes and other combusted tobacco products.

How the Study Was Run

To establish a codebook, the researchers randomly selected 300 tweets for hand-coding, including the attitudes (positive, neutral, and negative) toward VLNC (including its proposed rule) and major topics (13 topics).

The rest of the tweets were single-coded according to the codebook.

What Was Measured

On June 21, 2022, the US Food and Drug Administration (FDA) announced a plan to propose a rule to establish a maximum nicotine level in cigarettes and other combusted tobacco products.

PubMed files the paper under topics including Social Media, Public Opinion, Nicotine, United States, Tobacco Products and United States Food and Drug Administration.

Author keywords: Twitter, content analysis, observational study, public perception and very low nicotine.

What This Means in Plain Language

This is an observational study of Therapeutic nicotine (patch, non-peptide).

Results are reported in around 6 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2024 (JMIR formative research), a journal based in Canada.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.